QUOTE AND NEWS
Benzinga  Feb 28  Comment 
In a report published Friday, Bank of America analyst Erin E. Wilson downgraded the rating on Abaxis (NASDAQ: ABAX) from Neutral to Underperform, and lowered the price target from $36.00 to $35.00. In the report, Bank of America noted,...
SeekingAlpha  Jan 31  Comment 
ABAXIS, Inc. (ABAX) F3Q 2014 (Qtr End 12/31/2013) Earnings Call January 30, 2014, 4:15 PM ET Executives Joe Diaz - Lytham Partners Clinton Severson - Chairman, President and Chief Executive Officer Alberto Santa Ines - Chief...
StreetInsider.com  Jan 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Abaxis%2C+Inc.+%28ABAX%29+Misses+Q3+EPS+by+6c/9108076.html for the full story.
Benzinga  Jan 30  Comment 
Below are the small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $225.21 million. Neogen's ROE for the same period is 10.59%. The...
Benzinga  Dec 18  Comment 
Below are the small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Neogen (NASDAQ: NEOG) is $216.35 million. Neogen's ROE for the same period is 11.22%. The...
Benzinga  Nov 4  Comment 
In a report published Monday, Bank of America analyst Erin E. Wilson upgraded the rating on Abaxis (NASDAQ: ABAX) from Underperform to Neutral, and reiterated the $36.00 price target. In the report, Bank of America noted, “ABAX's shares have...
StreetInsider.com  Nov 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/BofAMerrill+Lynch+Upgrades+Abaxis+Inc.+%28ABAX%29+to+Neutral/8839861.html for the full story.
Forbes  Oct 29  Comment 
Although shares have fallen after the Q3 report, Abaxis' stock still looks pricey at 33 times forward earnings. Investors should consider waiting for earnings momentum to turn around before investing.
StreetInsider.com  Oct 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Abaxis+%28ABAX%29%2C+LamdaGen+Enter+Development+Agreement/8811219.html for the full story.
StreetInsider.com  Oct 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Abaxis%2C+Inc.+%28ABAX%29+Misses+Q2+EPS+by+3c/8799967.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki